Drug:
Reaction: OFF LABEL USE
20260101 - 20261231
No. 301 - 400
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 301 | 26557812 |
19 | 1 | |
Diffuse alveolar damage, Acute respiratory failure, Pulmonary fibrosis, Pneumothorax, Pulmonary pneumatocele, Off label use, |
||||
VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, CEFEPIME HYDROCHLORIDE, CEFEPIME, |
||||
| 302 | 26557818 |
US |
1 | |
Cataract, Irritability, Off label use, |
||||
PIMAVANSERIN TARTRATE, IRON, |
||||
| 303 | 26557819 |
US |
62 | |
Loss of consciousness, Heart rate decreased, Blood glucose decreased, Injection site discolouration, Throat tightness, Eye swelling, Injection site swelling, Injection site erythema, Injection site pruritus, Dyspnoea, Injection site pain, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 304 | 26557822 |
US |
||
Adverse reaction, Injection site swelling, Drug hypersensitivity, Off label use, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 305 | 26557835 |
40 | 1 | |
Condition aggravated, Off label use, |
||||
MYCOPHENOLIC ACID, MYCOPHENILIC ACID, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, RITUXIMAB, RITUXIMAB, |
||||
| 306 | 26557840 |
US |
13 | |
Full blood count increased, Intentional product use issue, Off label use, |
||||
ANAKINRA, |
||||
| 307 | 26557849 |
US |
||
Dysphagia, Muscular weakness, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 308 | 26557850 |
US |
||
Drug effect less than expected, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 309 | 26557851 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 310 | 26557853 |
US |
||
Drug effect less than expected, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 311 | 26557854 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 312 | 26557855 |
US |
40 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 313 | 26557856 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 314 | 26557907 |
ZA |
1 | |
Retinal thickening, Off label use, |
||||
FARICIMAB, FARICIMAB, FARICIMAB, |
||||
| 315 | 26557915 |
US |
||
Adverse event, Off label use, |
||||
LENALIDOMIDE, |
||||
| 316 | 26557954 |
US |
62 | 2 |
Pneumonitis aspiration, Psoriatic arthropathy, Psoriasis, Hair texture abnormal, Alopecia, Erythema, Obesity, Vein disorder, Treatment failure, Off label use, Peripheral swelling, Liver disorder, Bone loss, Poor quality sleep, |
||||
APREMILAST, APREMILAST, ROMOSOZUMAB-AQQG, ETANERCEPT, UPADACITINIB, METHOTREXATE, METHOTREXATE SODIUM, FOLIC ACID, GUSELKUMAB, IXEKIZUMAB, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, |
||||
| 317 | 26557974 |
US |
75 | 2 |
Accidental exposure to product, Exposure via skin contact, Off label use, |
||||
INSULIN GLARGINE, |
||||
| 318 | 26558029 |
US |
65 | 2 |
Off label use, |
||||
INSULIN GLARGINE, |
||||
| 319 | 26558039 |
US |
57 | 1 |
Off label use, |
||||
INSULIN GLARGINE, |
||||
| 320 | 26558044 |
US |
73 | |
Off label use, |
||||
DRONEDARONE, |
||||
| 321 | 26558056 |
US |
5 | 1 |
Off label use, |
||||
DUPILUMAB, |
||||
| 322 | 26558107 |
US |
73 | 2 |
Dehydration, Vomiting, Nausea, Off label use, |
||||
TIRZEPATIDE, |
||||
| 323 | 26558113 |
US |
73 | |
Off label use, |
||||
INSULIN GLARGINE, |
||||
| 324 | 26558161 |
US |
55 | |
Off label use, |
||||
INSULIN GLARGINE, |
||||
| 325 | 26558172 |
US |
1 | |
Off label use, |
||||
DUPILUMAB, |
||||
| 326 | 26558253 |
US |
58 | |
Fatigue, Asthenia, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 327 | 26558259 |
US |
35 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 328 | 26558262 |
US |
51 | |
Drug effect less than expected, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 329 | 26558263 |
US |
43 | |
Periorbital swelling, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 330 | 26558264 |
US |
||
Periorbital swelling, Injection site bruising, Vision blurred, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 331 | 26558299 |
EU |
45 | 2 |
Substance use disorder, Withdrawal syndrome, Off label use, |
||||
BUPRENORPHINE, BUPRENORPHINE, METHADONE, |
||||
| 332 | 26558308 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 333 | 26558431 |
NZ |
31 | 2 |
Drug ineffective for unapproved indication, Off label use, Maternal exposure during pregnancy, Normal newborn, Product prescribing issue, |
||||
HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, SPIRONOLACTONE, SPIRONOLACTONE, SPIRONOLACTONE, SPIRONOLACTONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, |
||||
| 334 | 26558449 |
CA |
25 | |
Condition aggravated, Drug level decreased, Maternal exposure during pregnancy, Therapeutic response shortened, Off label use, Off label use, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, AZATHIOPRINE, |
||||
| 335 | 26558461 |
US |
19 | 2 |
Off label use, |
||||
PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, |
||||
| 336 | 26558482 |
US |
||
Off label use, Product dose omission issue, |
||||
LENALIDOMIDE, |
||||
| 337 | 26558484 |
US |
||
Pneumonia, Respiratory syncytial virus infection, Off label use, |
||||
LENALIDOMIDE, |
||||
| 338 | 26558528 |
CA |
75 | |
Blood pressure diastolic decreased, Blood pressure systolic increased, Heart rate decreased, Hypertension, Influenza, Intentional product use issue, Off label use, Intentional product use issue, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, CHOLESTYRAMINE, CHOLESTYRAMINE, CHOLESTYRAMINE, AZATHIOPRINE, DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE ORAL, |
||||
| 339 | 26558577 |
US |
2 | |
Off label use, Off label use, Menstruation delayed, Therapeutic product effect incomplete, |
||||
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL AND FERROUS FUMARATE, NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL AND FERROUS FUMARATE, NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL AND FERROUS FUMARATE, NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL AND FERROUS FUMARATE, |
||||
| 340 | 26558580 |
US |
10 | 1 |
Colitis ulcerative, Off label use, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, |
||||
| 341 | 26558722 |
GB |
73 | 2 |
Blood glucose decreased, Pleural effusion, Lower respiratory tract infection, Nerve injury, Pain in extremity, Contusion, Pyrexia, Gait inability, Dyspnoea, Burning feet syndrome, Off label use, |
||||
TRAMETINIB, TRAMETINIB, DABRAFENIB, DABRAFENIB, MIRTAZAPINE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, |
||||
| 342 | 26558755 |
EU |
18 | |
Ependymoma, Off label use, |
||||
BEVACIZUMAB, |
||||
| 343 | 26558764 |
81 | ||
Off label use, |
||||
RUXOLITINIB, RUXOLITINIB, |
||||
| 344 | 26558787 |
AU |
28 | |
Postpartum haemorrhage, Maternal exposure during pregnancy, Off label use, |
||||
HUMAN IMMUNOGLOBULIN G, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, HYDROXYCHLOROQUINE, |
||||
| 345 | 26558788 |
AU |
||
Foetal growth restriction, Foetal exposure during pregnancy, Off label use, |
||||
HUMAN IMMUNOGLOBULIN G, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, HYDROXYCHLOROQUINE, |
||||
| 346 | 26558789 |
AU |
||
Foetal growth restriction, Foetal exposure during pregnancy, Off label use, |
||||
HUMAN IMMUNOGLOBULIN G, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, HYDROXYCHLOROQUINE, |
||||
| 347 | 26558793 |
US |
50 | 1 |
Mental status changes, Drug dependence, Hyponatraemia, Tachypnoea, Drug abuse, Off label use, Polydipsia psychogenic, Tachycardia, Intentional product misuse, Pyrexia, Drug withdrawal syndrome, Hypertension, Agitation, |
||||
OLANZAPINE, CLONIDINE, |
||||
| 348 | 26558810 |
US |
59 | 2 |
Fatigue, Systemic lupus erythematosus, Gait disturbance, Off label use, |
||||
ABATACEPT, |
||||
| 349 | 26558823 |
2 | ||
Tumour obstruction, Off label use, |
||||
CETUXIMAB, OXALIPLATIN, MONTELUKAST, LORATADINE, LORATADINE ORAL, TELMISARTAN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, GRANISETRON, GRANISETRON HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, CAPECITABINE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, CELECOXIB, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 350 | 26558831 |
58 | 1 | |
Neutropenia, Off label use, |
||||
CETUXIMAB, CETUXIMAB, OXALIPLATIN, |
||||
| 351 | 26558837 |
EU |
61 | 2 |
Hypercalcaemia, Anaemia, Thrombocytopenia, Off label use, |
||||
BEVACIZUMAB, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 352 | 26558849 |
BR |
44 | 2 |
Device leakage, Incorrect dose administered by device, Wrong technique in product usage process, Off label use, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, BUPROPION, DESVENLAFAXINE, DESVENLAFAXINE SUCCINATE, |
||||
| 353 | 26558869 |
US |
48 | 2 |
Off label use, |
||||
PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, |
||||
| 354 | 26558926 |
US |
2 | |
Food allergy, Upper respiratory tract infection, Off label use, Drug delivery system malfunction, |
||||
IPRATROPIUM BROMIDE AND ALBUTEROL, IPRATROPIUM BROMIDE AND ALBUTEROL, |
||||
| 355 | 26558996 |
CN |
73 | 2 |
Renal failure, Off label use, |
||||
| 356 | 26559069 |
JM |
62 | 1 |
Retinal detachment, Glaucoma, Blood glucose fluctuation, Off label use, Off label use, Visual acuity reduced, |
||||
FARICIMAB, BEVACIZUMAB, BEVACIZUMAB, BEVACIZUMAB, |
||||
| 357 | 26559072 |
AU |
28 | |
Postpartum haemorrhage, Maternal exposure during pregnancy, Off label use, |
||||
HUMAN IMMUNOGLOBULIN G, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, HYDROXYCHLOROQUINE, |
||||
| 358 | 26559078 |
TR |
8 | |
Retinoschisis, Vitreous adhesions, Off label use, |
||||
BEVACIZUMAB, |
||||
| 359 | 26559083 |
GB |
53 | 1 |
Alcohol poisoning, Accidental overdose, Abdominal discomfort, Burns second degree, Cardiac murmur, Catarrh, Cerebrovascular accident, Confusional state, Drug ineffective, Depression, Dysgeusia, Fatigue, Eczema, Frequent bowel movements, Gingival pain, Haematochezia, Hypopnoea, Inappropriate schedule of product administration, Migraine, Headache, Nightmare, Off label use, Pain, Pain in extremity, Palpitations, Parosmia, Pulmonary embolism, Pyrexia, Rash, Rectal haemorrhage, Rhinitis, Somnolence, Steroid dependence, Stress, Swollen tongue, Systemic lupus erythematosus, Tinnitus, Tubulointerstitial nephritis, Vertigo, Weight decreased, Impaired quality of life, Loss of personal independence in daily activities, Impaired work ability, Medication error, Product use in unapproved indication, Intentional product use issue, |
||||
CANDESARTAN CILEXETIL, LATANOPROST, FESOTERODINE FUMARATE, BUDESONIDE, FELODIPINE, FELODIPINE EXTENDED-RELEASE TABLETS, ROSUVASTATIN, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, DAPAGLIFLOZIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ROSUVASTATIN, HYDROCORTISONE ACETATE, HYDROCORTISONE, VEDOLIZUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, OXYCODONE, ERGOCALCIFEROL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE, LISDEXAMFETAMINE DIMESYLATE CAPSULES, WARFARIN SODIUM, WARFARIN, VEDOLIZUMAB, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, FUROSEMIDE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ADALIMUMAB, INFLIXIMAB-DYYB, LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE, LISDEXAMFETAMINE DIMESYLATE CAPSULES, DESOXIMETASONE, ACETAMINOPHEN, DEXTROMETHORPHAN HBR, ACETAMINOPHEN AND DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN AND PHENYLEPRINE HCL, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR, PRAVASTATIN SODIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, RAMIPRIL, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ESOMEPRAZOLE MAGNESIUM, AMLODIPINE BESYLATE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, DORZOLAMIDE HYDROCHLORIDE, DORZOLAMIDE, RIVAROXABAN, METHOTREXATE, METHOTREXATE SODIUM, TAMSULOSIN HYDROCHLORIDE, FOLIC ACID, TOFACITINIB, BISOPROLOL FUMARATE, EMPAGLIFLOZIN, LANSOPRAZOLE, NITROFURANTOIN, NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE, PREGABALIN, LATANOPROST, MINERAL OIL, NAPHAZOLINE HYDROCHLORIDE, TOFACITINIB CITRATE, TETRAHYDROZOLINE HYDROCHLORIDE, CAFFEINE, CALCIUM CHLORIDE INJECTION, CALCIUM CHLORIDE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, CALCIUM CARBONATE, ANTACID, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, FELODIPINE, FELODIPINE EXTENDED-RELEASE TABLETS, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, DAPAGLIFLOZIN, LATANOPROST, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, ROSUVASTATIN, ROSUVASTATIN, HYDROCORTISONE ACETATE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, DESOXIMETASONE, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, ADALIMUMAB, ADALIMUMAB, VEDOLIZUMAB, WARFARIN SODIUM, WARFARIN, OXYCODONE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, ROSUVASTATIN, |
||||
| 360 | 26559089 |
EU |
41 | |
Malaria relapse, Drug ineffective for unapproved indication, Off label use, |
||||
DOXYCYCLINE, DOXYCYCLINE HYCLATE, |
||||
| 361 | 26559112 |
CA |
1 | |
Haematochezia, Impaired work ability, Social problem, Frequent bowel movements, Off label use, |
||||
VEDOLIZUMAB, SULFASALAZINE, |
||||
| 362 | 26559135 |
US |
2 | |
Anaphylactic reaction, Off label use, |
||||
OMALIZUMAB, |
||||
| 363 | 26559140 |
US |
2 | |
Arthritis, Platelet count decreased, Pain, Arthritis infective, Off label use, |
||||
TOCILIZUMAB, |
||||
| 364 | 26559153 |
EU |
||
Haematotoxicity, Off label use, |
||||
RUXOLITINIB, BARICITINIB, BARICITINIB, TOFACITINIB, TOFACITINIB CITRATE, TOFACITINIB, TOFACITINIB CITRATE, |
||||
| 365 | 26559230 |
CA |
45 | 2 |
Abdominal discomfort, Arthralgia, Autoimmune disorder, Blood cholesterol increased, Confusional state, Contusion, Decreased appetite, Deep vein thrombosis postoperative, Drug ineffective, Eye injury, Folliculitis, Gait inability, Gastrointestinal disorder, Headache, Helicobacter infection, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Incorrect route of product administration, Infection, Irritable bowel syndrome, Liver disorder, Lower respiratory tract infection, Lupus vulgaris, Maternal exposure during pregnancy, Muscle injury, Musculoskeletal stiffness, Nasopharyngitis, Nausea, Pemphigus, Peripheral swelling, Off label use, Pruritus, Rash, Rheumatic fever, Rheumatoid factor positive, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Vomiting, Wheezing, Wound, |
||||
TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, RITUXIMAB, |
||||
| 366 | 26559272 |
US |
||
Hospitalisation, Off label use, |
||||
BETAINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CANDESARTAN, DULOXETINE HYDROCHLORIDE, DULOXETINE, HYDROXYZINE, HYOSCYAMINE SULFATE, METOPROLOL TARTRATE, METOPROLOL, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, LASMIDITAN, CARISOPRODOL, THYROID, PORCINE, |
||||
| 367 | 26559291 |
CN |
14 | |
Acute lymphocytic leukaemia recurrent, Malignant neoplasm progression, Off label use, |
||||
RUXOLITINIB, TRAMETINIB, INOTUZUMAB OZOGAMICIN, VENETOCLAX, VENETOCLAX, VENETOCLAX, |
||||
| 368 | 26559316 |
EU |
85 | 1 |
Death, Intentional product use issue, Off label use, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, EMICIZUMAB, |
||||
| 369 | 26559346 |
CA |
67 | 1 |
Cardiac failure, Myocardial infarction, Colitis ulcerative, Nosocomial infection, Off label use, |
||||
GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CLOPIDOGREL, CLOPIDOGREL BISULFATE, BISOPROLOL FUMARATE, ISOSORBIDE MONONITRATE, RANITIDINE, ROSUVASTATIN, METRONIDAZOLE, METRONIDAZOLE TOPICAL, RABEPRAZOLE, BISMUTH SUBSALICYLATE, |
||||
| 370 | 26559357 |
33 | 2 | |
Central nervous system immune reconstitution inflammatory response, Off label use, Maternal exposure during pregnancy, |
||||
LINEZOLID, LINEZOLID, MEROPENEM, MEROPENEM, CYCLOSERINE, CYCLOSERINE, AMIKACIN, AMIKACIN, MANNITOL, MANNITOL, CLOPIDOGREL, CLOPIDOGREL BISULFATE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 371 | 26559362 |
US |
67 | 1 |
Gastrointestinal injury, Nausea, Abdominal pain, Vomiting, Anxiety, Off label use, |
||||
SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 372 | 26559384 |
CA |
73 | 1 |
Blood pressure increased, Cough, Eye irritation, Eye oedema, Eye pruritus, Ocular hyperaemia, Off label use, Respiratory tract irritation, Throat irritation, Wheezing, |
||||
RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, |
||||
| 373 | 26559448 |
CN |
42 | 2 |
Abortion spontaneous, Maternal exposure during pregnancy, Off label use, |
||||
LETROZOLE, LETROZOLE TABLETS, LETROZOLE, LETROZOLE TABLETS, |
||||
| 374 | 26559475 |
CA |
44 | 2 |
Malignant neoplasm progression, Fungal skin infection, Contusion, Fatigue, Diarrhoea, Blood pressure increased, Laryngitis, Chest pain, Malaise, Off label use, Vomiting, Diarrhoea, Gastroenteritis viral, Dehydration, Off label use, |
||||
LANREOTIDE ACETATE, CABOZANTINIB, CABOZANTINIB, |
||||
| 375 | 26559478 |
US |
1 | |
Off label use, |
||||
| 376 | 26559502 |
US |
37 | |
Swollen tongue, Paraesthesia oral, Pharyngeal paraesthesia, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 377 | 26559521 |
US |
68 | 1 |
Portal venous gas, Off label use, |
||||
PACLITAXEL, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, APIXABAN, CEFDINIR, |
||||
| 378 | 26559621 |
US |
37 | |
Hypertriglyceridaemia, Pancreatitis acute, Off label use, |
||||
RUXOLITINIB, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, PEMBROLIZUMAB, PEMBROLIZUMAB, DEXTROSE MONOHYDRATE, DEXTROSE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 379 | 26559624 |
EU |
39 | 2 |
Therapy non-responder, Maternal exposure during pregnancy, Off label use, Blood pressure increased, Normal newborn, |
||||
CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CYCLOSPORINE, OMALIZUMAB, PREDNISONE, |
||||
| 380 | 26559637 |
AU |
75 | 1 |
Renal failure, Multiple organ dysfunction syndrome, Septic shock, Systemic candida, Splenic abscess, Liver abscess, Acute kidney injury, Oedema, Candida infection, Drug ineffective, Off label use, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, ANAKINRA, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, TOCILIZUMAB, CASPOFUNGIN ACETATE, DEXAMETHASONE SODIUM PHOSPHATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, PEMBROLIZUMAB, PENICILLIN G SODIUM, ACYCLOVIR, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE BITARTRATE, GENTAMICIN SULFATE, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, MEROPENEM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, TRIMETHOPRIM, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, PEMBROLIZUMAB, |
||||
| 381 | 26559644 |
GB |
52 | 2 |
Insomnia, Off label use, |
||||
DULOXETINE HYDROCHLORIDE, DULOXETINE, DARIDOREXANT, |
||||
| 382 | 26559652 |
US |
||
Flatulence, Nausea, Off label use, |
||||
SELINEXOR, ROSUVASTATIN, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, LEVETIRACETAM, LAMOTRIGINE, ESCITALOPRAM, MIDAZOLAM, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PROPRANOLOL HYDROCHLORIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 383 | 26559678 |
BR |
16 | 2 |
Crohn^s disease, Antibody test abnormal, Weight increased, Inappropriate schedule of product administration, Drug level decreased, Off label use, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, AZATHIOPRINE, |
||||
| 384 | 26559682 |
US |
||
Syncope, Off label use, |
||||
RUXOLITINIB, RUXOLITINIB, |
||||
| 385 | 26559690 |
US |
1 | |
Off label use, |
||||
SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, TREPROSTINIL, |
||||
| 386 | 26559693 |
EU |
41 | 2 |
Stillbirth, Maternal exposure during pregnancy, Off label use, |
||||
| 387 | 26559854 |
US |
27 | 2 |
Off label use, Injection site pain, |
||||
TIRZEPATIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, PRAZOSIN, GABAPENTIN, FLUOXETINE HYDROCHLORIDE, DOXEPIN, DOXEPIN HYDROCHLORIDE, |
||||
| 388 | 26559859 |
US |
1 | |
Swelling face, Rash, Feeling hot, Dizziness, Off label use, |
||||
PEGVALIASE-PQPZ, PEGVALIASE-PQPZ, |
||||
| 389 | 26559863 |
US |
16 | |
Arthralgia, Off label use, |
||||
PEGVALIASE-PQPZ, |
||||
| 390 | 26559881 |
US |
64 | 2 |
Alopecia, Off label use, Inappropriate schedule of product administration, Product physical issue, |
||||
PRASTERONE, PRASTERONE, |
||||
| 391 | 26559900 |
|||
Hallucination, Fatigue, Off label use, |
||||
METHOXSALEN, |
||||
| 392 | 26559933 |
US |
||
Off label use, |
||||
SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, |
||||
| 393 | 26559954 |
EG |
45 | 1 |
Acute kidney injury, Drug ineffective, Off label use, |
||||
ELTROMBOPAG, ELTROMBOPAG OLAMINE, ELTROMBOPAG, ELTROMBOPAG OLAMINE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, RITUXIMAB, PANTOPRAZOLE, CELECOXIB, |
||||
| 394 | 26559959 |
US |
2 | |
Cytokine release syndrome, Off label use, Vomiting, Diarrhoea, |
||||
DARATUMUMAB AND HYALURONIDASE-FIHJ (HUMAN RECOMBINANT), |
||||
| 395 | 26559972 |
US |
60 | 1 |
Intentional dose omission, Off label use, |
||||
POMALIDOMIDE, |
||||
| 396 | 26560015 |
2 | ||
Iron deficiency anaemia, Off label use, |
||||
METHOXSALEN, |
||||
| 397 | 26560055 |
US |
50 | 1 |
Off label use, |
||||
SPARSENTAN, |
||||
| 398 | 26560138 |
US |
76 | 2 |
Amyloid related imaging abnormality-microhaemorrhages and haemosiderin deposits, Amyloid related imaging abnormality-oedema/effusion, Cerebral haemorrhage, Migraine, Migraine, Vision blurred, Photopsia, Sleep disorder, Headache, Off label use, |
||||
ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, CAFFEINE, PREDNISONE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 399 | 26560145 |
75 | ||
Nasopharyngitis, Off label use, |
||||
RUXOLITINIB, |
||||
| 400 | 26560147 |
62 | 2 | |
Platelet-large cell count decreased, Platelet count decreased, Off label use, |
||||
ABEMACICLIB, ABEMACICLIB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28